"10.1371_journal.pone.0022346","plos one","2011-08-02T00:00:00Z","Peter Bager; Christian Kapel; Allan Roepstorff; Stig Thamsborg; John Arnved; Steen Rønborg; Bjarne Kristensen; Lars K Poulsen; Jan Wohlfahrt; Mads Melbye","Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark; Department of Agriculture and Ecology, Faculty of Life Sciences, University of Copenhagen, Frederiksberg, Denmark; Department of Veterinary Disease Biology, Faculty of Life Sciences, University of Copenhagen, Frederiksberg, Denmark; Pulmonology and Allergy Clinic of Copenhagen, Copenhagen, Denmark; Phadia ApS, Allerød, Denmark; National University Hospital, Allergy Clinic, Copenhagen, Denmark","Conceived and designed the experiments: PB MM. Performed the experiments: PB JA SR BK LP JW MM. Analyzed the data: PB MM JW. Contributed reagents/materials/analysis tools: PB CK AR ST JA SR BK LP JA MM. Wrote the paper: PB CK AR ST JA SR BK LP JA MM.","CK, ST, and AR are board members of Parasite Technologies A/S, a company that produces the raw material for the tested agent, T. suis ova. The rest of the authors have declared that they have no competing interests. There are no patents or marketed products to declare. T. suis ova is an agent being developed as therapy for inflammatory bowel disease. Parasite Technologies A/S provides raw material for the agent, and is otherwise not involved in the development. None of the interests alter the adherence to PLoS ONE policies on sharing data and materials.","2011","08","Peter Bager","PB",10,FALSE,2,7,3,9,TRUE,TRUE,FALSE,0,NA,FALSE
